Our Story

Developing safer, more durable treatments
to improve the lives of patients

AltruBio is developing first-in-class immune-modulators to target diseases of the immune system. Its world-class global team brings a breadth of expertise in immunology and drug development to bring their biologic treatments to patients.  

About Us

A Clinical-stage Biopharmaceutical Company.

AltruBio has clinically validated a first-in-class immune checkpoint regulator to selectively target unwanted T-cells.
Corporate Milestone

Achieving Results
in and out of the Lab.

Persistence is the path to success. Find more about AltruBio story.
Join us

United as one.
Talents of all areas, people of all origins, we are here under one purpose—
to improve people’s health.